Academic Journal of Second Military Medical University (第二军医大学学报) 2015/36:12 PP.1300-1303
Objective To investigate the protective effects of glutathione (GSH) against hepatic ischemia/reperfusion (I/R) injury and the related mechanism. Methods SD rats were randomized into Sham, I/R and GSH groups with 20 rats in each group. Rat models of segmental (70%) warm hepatic ischemia were established in I/R and GSH groups. GSH was injected through the femoral vein at the dose of 5 mg/kg 5 min before ischemia. At 24 h after reperfusion, liver injury was evaluated by serological and histological indices. Liver cell apoptoses were evaluated by TUNEL staining. The GSH/oxidized glutathione (GSSG) ratios of tissue level were compared between different groups. Liver mitochondria were collected and the mitochondrial calcium capacity (CRC) was evaluated. Results The serum aspartate transaminanse (AST) and alanine aminotransferase (ALT) levels in GSH group were significantly decreased 6 h after reperfusion compared with I/R group(P<0.05). 24 h after reperfusion, the liver injury was alleviated and the number of apoptosis cells was significantly decreased in GSH group compared with I/R group (P<0.05). The GSH/GSSG ratio of tissue level in GSH group was significantly increased 6 h after reperfusion compared with I/R group (P<0.05). Liver mitochondrial CRC in GSH group was significantly increased 6 h after reperfusion compared with I/R group (P<0.05). Conclusion GSH preconditioning can protect liver from hepatic I/R injury, which is possibly by inhibiting oxidative response and subsequent inhibition of mitochondrial permeability transition.
 Fu H, Chen H, Wang C, Xu H, Liu F, Guo M, et al. Flurbiprofen, a cyclooxygenase inhibitor, protects mice from hepatic ischemia/reperfusion injury by inhibiting GSK-3β signaling and mitochondrial permeability transition [J]. Mol Med, 2012, 18: 1128-1135.
 Fu H, Xu H, Chen H, Li Y, Li W, Zhu Q, et al. Inhibition of glycogen synthase kinase 3 ameliorates liver ischemia/reperfusion injury via an energy-dependent mitochondrial mechanism [J]. J Hepatol, 2014, 61: 816-824.
 Pardo A C, Rinaldi G J, Mosca S M. Mitochondrial calcium handling in normotensive and spontaneously hypertensive rats: correlation with systolic blood pressure levels[J]. Mitochondrion, 2015, 20: 75-81.
 Alchera E, Dal Ponte C, Imarisio C, Albano E, Carini R. Molecular mechanisms of liver preconditioning [J]. World J Gastroenterol, 2010, 16: 6058-6067.
 Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium[J]. Circulation, 1986, 74: 1124-1136.
 Zhang Y C, Zhang Q, Li H, Zhang J, Wang G S, Xu C, et al. Prognostic factors for late mortality after liver transplantation for benign end-stage liver disease[J]. Chin Med J (Engl), 2011, 124: 4229-4235.
 Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator[J]. J Neurosci, 1996, 16: 1066-1071.
 Lowicka E, Beltowski J.Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists[J]. Pharmacol Rep, 2007, 59: 4-24.
 Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress[J]. FASEB J, 2004, 18:1165-1167.
 Whiteman M, Li L, Kostetski I, Chu S H, Siau J L, Bhatia M, et al. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide [J]. Biochem Biophys Res Commun, 2006, 343: 303-310.
 Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues [J]. Eur J Biochem, 1999, 264: 687-701.
 Bauerfeld C P, Rastoqi R, Pirockinaite G, Lee I, Huttemann M, Monks B, et al. TLR4-mediated AKT activation is MYD88/TRIF-dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages[J]. J Immunol, 2012, 188:2847-2857.
 Hirsch J, Hansen K C, Choi S, Noh J, Hirose R, Roberts J P, et al. Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats[J]. Mol Cell Proteomics, 2006, 5:979-986.
 Picard C, Casanova J L, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency[J]. Clin Microbiol Rev, 2011, 24:490-497.
 Francis R C, Vaporidi K, Bloch K D, Ichinose F, Zaplo W M. Protective and detrimental effects of sodium sulfide and hydrogen sulfide in murine ventilator-induced lung injury[J]. Anesthesiology, 2011, 115: 1012-1021.